FDA Inspection 1070480 — Hangzhou Huadong Med. Group Kangrun Pharmaceutical Co Ltd
The FDA completed an inspection of Hangzhou Huadong Med. Group Kangrun Pharmaceutical Co Ltd on Sep 19, 2018 in Huzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 19, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Huzhou (China)